Percentage of free prostate-specific antigen: Implications in modern extended scheme prostate biopsy

Urology

Volumn 77, Issue 4, 2011, Pages 899-903

  Lee, Byron H ^a   Moussa, Ayman S ^a   Li, Jianbo ^a   Fareed, Khaled ^a   Jones, J Stephen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

AGED; AREA UNDER CURVE; BIOPSY, NEEDLE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 79953888351     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.06.072     Document Type: Article

References (27)

1. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate- specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156-1161.
2. Thompson IM, Ankerst DP, Chi C, et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2006;98:529-534. (Pubitemid 43898816)
3. Catalona WJ, Smith DS, Wolfert RL, et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA. 1995;274:1214-1220.
4. Lilja H, Christensson A, Dahlen U, et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem. 1991;37:1618-1625. (Pubitemid 21905228)
5. Stenman UH, Leinonen J, Alfthan H, et al. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res. 1991;51:222-226.
6. Christensson A, Bjork T, Nilsson O, et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J Urol. 1993;150:100-105. (Pubitemid 23175981)
7. Lee R, Localio AR, Armstrong K, et al. A meta-analysis of the performance characteristics of the free prostate-specific antigen test. Urology. 2006;67:762-768.
8. Lodding P, Aus G, Bergdahl S, et al. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng/mL prostate-specific antigen. J Urol. 1998;159:899-903. (Pubitemid 28106553)
9. Roddam AW, Duffy MJ, Hamdy FC, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/mL: systematic review and meta-analysis. Eur Urol. 2005;48:386-399.
10. Presti JC Jr. Prostate biopsy strategies. Nat Clin Pract Urol. 2007; 4:505-511.
11. Tan N, Lane BR, Li J, et al. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade. J Urol. 2008;180:1325-1329.
12. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med. 2004;350:2239-2246.
13. Djavan B, Zlotta A, Remzi M, et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol. 2000;163:1144-1149. (Pubitemid 30169380)
14. Fowler JE Jr, Bigler SA, Miles D, et al. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol. 2000;163:813-818. (Pubitemid 30091622)
15. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol. 1997;157:199-203. (Pubitemid 26414957)
16. de La Taille A, Antiphon P, Salomon L, et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology. 2003;61:1181-1186. (Pubitemid 36693999)
17. Presti JC Jr, O'Dowd GJ, Miller MC, et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol. 2003;169:125-129. (Pubitemid 35461569)
18. Singh H, Canto EI, Shariat SF, et al. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J Urol. 2004;171:1089-1092. (Pubitemid 38327533)
19. Elabbady AA, Khedr MM. Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score. Eur Urol. 2006;49:49-53. (Pubitemid 41789953)
20. Siu W, Dunn RL, Shah RB, et al. Use of extended pattern technique for initial prostate biopsy. J Urol. 2005;174:505-509. (Pubitemid 40981585)
21. Roehl KA, Antenor JA, Catalona WJ. Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 2.6 to 4.0 ng/mL. Range. J Urol. 2002;168:922-925.
22. Yokomizo Y, Miyoshi Y, Nakaigawa N, et al. Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy. Urol Int. 2009;82:280-285.
23. Chun FK, Briganti A, Graefen M, et al. Development and external validation of an extended repeat biopsy nomogram. J Urol. 2007;177:510-515. (Pubitemid 46054043)
24. Karakiewicz PI, Benayoun S, Kattan MW, et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol. 2005;173:1930-1934. (Pubitemid 40675214)
25. Basillote JB, Armenakas NA, Hochberg DA, et al. Influence of prostate volume in the detection of prostate cancer. Urology. 2003;61:167-171. (Pubitemid 36151735)
26. Eskicorapci SY, Guliyev F, Akdogan B, et al. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection. J Urol. 2005;173:1536-1540. (Pubitemid 40524767)
27. Letran JL, Meyer GE, Loberiza FR, et al. The effect of prostate volume on the yield of needle biopsy. J Urol. 1998;160:1718-1721. (Pubitemid 128746744)